title: [Visual disturbance].
authors.affiliation: Department of Ophthalmology, Nerima-Hikarigaoka Hospital, Nihon University School of Medicine.
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Yamazaki
authors.forename: Ai
authors.initials: A
authors.lastname: Yamada
authors.forename: Satoshi
authors.initials: S
authors.lastname: Sugaya
authors.forename: Akira
authors.initials: A
authors.lastname: Osawa
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects; D000995:Antitubercular Agents / Q000009:adverse effects; D002386:Cataract / Q000139:chemically induced; D056833:Central Serous Chorioretinopathy / Q000139:chemically induced; D003318:Corneal Opacity / Q000139:chemically induced; D004977:Ethambutol / Q000009:adverse effects; D005901:Glaucoma / Q000139:chemically induced; D006801:Humans; D007372:Interferons / Q000009:adverse effects; D058986:Phosphodiesterase 5 Inhibitors / Q000009:adverse effects; D010879:Piperazines / Q000009:adverse effects; D011687:Purines / Q000009:adverse effects; D000068677:Sildenafil Citrate; D013256:Steroids / Q000009:adverse effects; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced; D013450:Sulfones / Q000009:adverse effects; D005641:Tegafur / Q000009:adverse effects; D014786:Vision Disorders / Q000139:chemically induced*
chemical_list: D000964:Antimetabolites, Antineoplastic; D000995:Antitubercular Agents; D058986:Phosphodiesterase 5 Inhibitors; D010879:Piperazines; D011687:Purines; D013256:Steroids; D013450:Sulfones; D005641:Tegafur; D004977:Ethambutol; D007372:Interferons; D000068677:Sildenafil Citrate